Skip to content

Quality

Committed to Quality, Traceability and Responsible Conduct

Scarley is committed to working with appropriately licensed manufacturing and supply partners and to maintaining product documentation, traceability and responsible promotional practices in accordance with applicable requirements.

Product Documentation

Batch-level documentation and traceable records.

Vendor & Manufacturing Partner Assessment

Working only with appropriately licensed partners.

Batch Traceability

Structured records supporting responsible recall management.

Storage & Distribution Responsibility

Environment-appropriate handling across the supply chain.

Promotional Material Review

Balanced, referenced, approved-information-first content.

Complaint Handling

Structured triage and response for product complaints.

Pharmacovigilance

Adverse event capture and appropriate onward reporting.

Applicable Regulatory Compliance

Aligned to Indian regulatory expectations for our activities.

Corporate Summary

Legal & Corporate

Legal entity
SCARLEY PHARMACEUTICALS PRIVATE LIMITED
Business structure
Private Limited Company
Registered state
Assam
Primary place of business
Garchuk, Guwahati, Assam – 781035

FSSAI Compliance

Food Business Licence

Scarley Pharmaceuticals Private Limited holds an applicable Assam State food-business licence for authorised wholesaler and distributor activities.

Licence type
State Licence
Licence number
Available on request
Licensed activities
Trade/Retail – Distributor · Trade/Retail – Wholesaler
Authorised premises
Near DPS, Bhabananda Boro Path, P.O. Garchuk, Guwahati, Kamrup Metropolitan, Assam – 781035
Issued
9 July 2026
Fee paid up to
8 July 2029

The FSSAI licence applies to authorised food-category activities at the Assam premises and does not apply to every pharmaceutical product or to the Mailing Office in Maharashtra.

A note on regulatory claims

Scarley does not claim WHO-GMP, USFDA, ISO, DCGI or NABL status, and does not represent itself as owning a manufacturing facility. Any such claim will be published only where specific documentary evidence has been reviewed and approved.